Physician

Alan R Hromas, MD

According to 2025 Medicare claims, Alan Hromas, MD (NPI: 1437475902) practices ophthalmology in the Tulsa, OK market, with the plurality of this provider's patient population coming from Tulsa, OK. This provider's primary affiliated billing organization is TULSA RETINA CONSULTANTS PLLC (NPI: 1205263126; TIN: 46-3683868) and primary practice location at 74114-1704.

Hromas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 969 traditional Medicare patients, billed 68,706 HCPCS/CPT codes, and received $2,677,431 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 373 prescription claims across 149 beneficiaries totaling $14,243 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 35 records totaling $30,736. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $26,158 to $2,677,431. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $5,608 and ending at $14,243. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.7M2015 Medicare payment: $26,158 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $455,337 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,289,337 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,590,369 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,548,495 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $107,359 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $872,746 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $966,053 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,188,111 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,677,431 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015124151$26,158
20167204,097$455,337
20171,30411,771$1,289,337
20181,45512,119$1,590,369
20191,32912,103$1,548,495
2020202613$107,359
20217525,206$872,746
20228166,172$966,053
20231,00941,720$2,188,111
202496968,706$2,677,431

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$11K$23K2015 Drug cost: $5,608 (USD; Tot_Drug_Cst)2016 Drug cost: $7,319 (USD; Tot_Drug_Cst)2017 Drug cost: $16,536 (USD; Tot_Drug_Cst)2018 Drug cost: $22,443 (USD; Tot_Drug_Cst)2019 Drug cost: $22,370 (USD; Tot_Drug_Cst)2020 Drug cost: $11,806 (USD; Tot_Drug_Cst)2021 Drug cost: $17,267 (USD; Tot_Drug_Cst)2022 Drug cost: $19,658 (USD; Tot_Drug_Cst)2023 Drug cost: $22,510 (USD; Tot_Drug_Cst)2024 Drug cost: $14,243 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152756$5,608
201667159$7,319
2017130424$16,536
2018145497$22,443
2019142515$22,370
2020110305$11,806
2021120311$17,267
2022155340$19,658
2023185408$22,510
2024149373$14,243

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more379416$98
67028Injection of drug into eye4031,513$91
92014Established patient complete exam of visual system379430$75
92134Imaging of retina8992,501$28
J2777Injection, faricimab-svoa, 0.1 mg21259,400$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate2037,971$5,915
DifluprednateDifluprednate12214$1,139
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat473,604$681
Atropine SulfateAtropine Sulfate13471$338
Dorzolamide HclDorzolamide Hcl151,035$286

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.27$691Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.8$30,045Alimera Sciences, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alan R. Hromas, MD?

Tedicare shows public-source Medicare data for Alan R. Hromas, MD (NPI 1437475902), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan R. Hromas, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alan R. Hromas, MD?

Alan R. Hromas, MD is linked to TULSA RETINA CONSULTANTS PLLC (billing NPI 1205263126) in the available physician profile data.

Does Alan R. Hromas, MD have Open Payments data?

Alan R. Hromas, MD has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.